KYTX shows severe cash burn acceleration with operating cash flow deteriorating 34.5% to -$153.7M while R&D expenses surged 18.9%, indicating unsustainable spending trajectory despite increased cash position.
The company is burning through cash at an alarming rate with operating losses expanding to -$161.3M, raising serious questions about runway duration and the need for additional financing. While cash increased to $124.1M, the accelerating burn rate of $153.7M annually suggests less than 12 months of runway at current spending levels, creating immediate liquidity pressure.
KYTX exhibits a classic biotech cash burn crisis with operating cash flow deteriorating 34.5% to -$153.7M while R&D expenses jumped 18.9% to $133.7M, driving net losses to -$161.3M. Despite cash increasing to $124.1M (likely from financing activities), the company faces severe runway constraints with current burn rates exceeding cash on hand annually. The 61.7% surge in total liabilities to $61.5M combined with declining stockholder equity signals mounting financial stress and imminent need for capital raises or strategic alternatives.
Capex reduced 99.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Liabilities grew 61.7% — significant increase in debt or obligations, assess impact on financial flexibility.
Operating cash flow fell 34.5% — earnings quality concerns; investigate working capital changes and non-cash items.
Cash grew 28.4% — improving liquidity position supports investment and shareholder returns.
Net income declined 26.5% — review whether driven by operations, interest costs, or non-recurring items.
Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.
R&D investment increased 18.9% — signals commitment to future product development, though near-term margin impact.
Equity decreased 12.9% — buybacks or losses reducing book value, monitor solvency ratios.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →